These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17118181)

  • 1. Improving the use of research evidence in guideline development: 1. Guidelines for guidelines.
    Schünemann HJ; Fretheim A; Oxman AD;
    Health Res Policy Syst; 2006 Nov; 4():13. PubMed ID: 17118181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the use of research evidence in guideline development: 3. Group composition and consultation process.
    Fretheim A; Schünemann HJ; Oxman AD
    Health Res Policy Syst; 2006 Nov; 4():15. PubMed ID: 17134482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the use of research evidence in guideline development: 16. Evaluation.
    Oxman AD; Schünemann HJ; Fretheim A
    Health Res Policy Syst; 2006 Dec; 4():28. PubMed ID: 17156460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the use of research evidence in guideline development: 13. Applicability, transferability and adaptation.
    Schünemann HJ; Fretheim A; Oxman AD
    Health Res Policy Syst; 2006 Dec; 4():25. PubMed ID: 17156457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the use of research evidence in guideline development: 8. Synthesis and presentation of evidence.
    Oxman AD; Schünemann HJ; Fretheim A
    Health Res Policy Syst; 2006 Dec; 4():20. PubMed ID: 17147809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the use of research evidence in guideline development: 10. Integrating values and consumer involvement.
    Schünemann HJ; Fretheim A; Oxman AD
    Health Res Policy Syst; 2006 Dec; 4():22. PubMed ID: 17147811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the use of research evidence in guideline development: 2. Priority setting.
    Oxman AD; Schünemann HJ; Fretheim A
    Health Res Policy Syst; 2006 Nov; 4():14. PubMed ID: 17134481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the use of research evidence in guideline development: 9. Grading evidence and recommendations.
    Schünemann HJ; Fretheim A; Oxman AD
    Health Res Policy Syst; 2006 Dec; 4():21. PubMed ID: 17147810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the use of research evidence in guideline development: 12. Incorporating considerations of equity.
    Oxman AD; Schünemann HJ; Fretheim A
    Health Res Policy Syst; 2006 Dec; 4():24. PubMed ID: 17147814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the use of research evidence in guideline development: 14. Reporting guidelines.
    Oxman AD; Schünemann HJ; Fretheim A
    Health Res Policy Syst; 2006 Dec; 4():26. PubMed ID: 17156458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the use of research evidence in guideline development: 6. Determining which outcomes are important.
    Schünemann HJ; Oxman AD; Fretheim A
    Health Res Policy Syst; 2006 Dec; 4():18. PubMed ID: 17140444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving the use of research evidence in guideline development: 11. Incorporating considerations of cost-effectiveness, affordability and resource implications.
    Edejer TT
    Health Res Policy Syst; 2006 Dec; 4():23. PubMed ID: 17147813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the use of research evidence in guideline development: 15. Disseminating and implementing guidelines.
    Fretheim A; Schünemann HJ; Oxman AD
    Health Res Policy Syst; 2006 Dec; 4():27. PubMed ID: 17156459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the use of research evidence in guideline development: 7. Deciding what evidence to include.
    Oxman AD; Schünemann HJ; Fretheim A
    Health Res Policy Syst; 2006 Dec; 4():19. PubMed ID: 17140445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the use of research evidence in guideline development: 4. Managing conflicts of interests.
    Boyd EA; Bero LA
    Health Res Policy Syst; 2006 Dec; 4():16. PubMed ID: 17140441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the use of research evidence in guideline development: 5. Group processes.
    Fretheim A; Schünemann HJ; Oxman AD
    Health Res Policy Syst; 2006 Dec; 4():17. PubMed ID: 17140442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moving from evidence to developing recommendations in guidelines: article 11 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
    Schünemann HJ; Oxman AD; Akl EA; Brozek JL; Montori VM; Heffner J; Hill S; Woodhead M; Campos-Outcalt D; Alderson P; Woitalla T; Puhan MA; Falck-Ytter Y; Bousquet J; Guyatt G;
    Proc Am Thorac Soc; 2012 Dec; 9(5):282-92. PubMed ID: 23256172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
    Teede HJ; Tay CT; Laven JJE; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; Redman LM; Boyle JA; Norman RJ; Mousa A; Joham AE
    J Clin Endocrinol Metab; 2023 Sep; 108(10):2447-2469. PubMed ID: 37580314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.